{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:02:29Z","timestamp":1791597749780,"version":"4.3.4"},"reference-count":65,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Despite high cure rates in classic Hodgkin lymphoma (cHL), relapses are observed. Whether relapsed cHL represents second primary lymphoma or an underlying T-cell lymphoma (TCL) mimicking cHL is underinvestigated. To analyze the nature of cHL recurrences, in-depth clonality testing of immunoglobulin (Ig) and T-cell receptor (TCR) rearrangements was performed in paired cHL diagnoses and recurrences among 60 patients, supported by targeted mutation analysis of lymphoma-associated genes. Clonal Ig rearrangements were detected by next-generation sequencing (NGS) in 69 of 120 (58%) diagnoses and recurrence samples. The clonal relationship could be established in 34 cases, identifying clonally related relapsed cHL in 24 of 34 patients (71%). Clonally unrelated cHL was observed in 10 of 34 patients (29%) as determined by IG-NGS clonality assessment and confirmed by the identification of predominantly mutually exclusive gene mutations in the paired cHL samples. In recurrences of &amp;gt;2 years, \u223c60% of patients with cHL for whom the clonal relationship could be established showed a second primary cHL. Clonal TCR gene rearrangements were identified in 14 of 125 samples (11%), and TCL-associated gene mutations were detected in 7 of 14 samples. Retrospective pathology review with integration of the molecular findings were consistent with an underlying TCL in 5 patients aged &amp;gt;50 years. This study shows that cHL recurrences, especially after 2 years, sometimes represent a new primary cHL or TCL mimicking cHL, as uncovered by NGS-based Ig\/TCR clonality testing and gene mutation analysis. Given the significant therapeutic consequences, molecular testing of a presumed relapse in cHL is crucial for subsequent appropriate treatment strategies adapted to the specific lymphoma presentation.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010412","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T14:05:28Z","timestamp":1691503528000},"page":"5911-5924","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":10,"title":["A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-2807","authenticated-orcid":false,"given":"Diede A. G.","family":"van Bladel","sequence":"first","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B. C.","family":"Stevens","sequence":"additional","affiliation":[{"name":"2Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-1742","authenticated-orcid":false,"given":"Leonie I.","family":"Kroeze","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben A. L.","family":"de Groen","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur A.","family":"de Groot","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-9935","authenticated-orcid":false,"given":"Jessica L. M.","family":"van der Last-Kempkes","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine R.","family":"Berendsen","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Rijntjes","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen A. C. W.","family":"Luijks","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bonzheim","sequence":"additional","affiliation":[{"name":"4Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van der Spek","sequence":"additional","affiliation":[{"name":"5Department of Hematology, Rijnstate Hospital, Arnhem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-9460","authenticated-orcid":false,"given":"Wouter J.","family":"Plattel","sequence":"additional","affiliation":[{"name":"6Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes F. M.","family":"Pruijt","sequence":"additional","affiliation":[{"name":"7Department of Hematology, Jeroen Bosch Hospital, \u2018s-Hertogenbosch, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D. P. W. M.","family":"de Jonge-Peeters","sequence":"additional","affiliation":[{"name":"8Department of Hematology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjo A.","family":"Velders","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Lensen","sequence":"additional","affiliation":[{"name":"10Department of Hematology, Bernhoven Hospital, Uden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther R.","family":"van Bladel","sequence":"additional","affiliation":[{"name":"11Department of Internal Medicine, Slingeland Hospital, Doetinchem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Federmann","sequence":"additional","affiliation":[{"name":"4Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"},{"name":"12Department of Translational Immunology, German Cancer Research Center, Medical Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigiet M.","family":"Hoevenaars","sequence":"additional","affiliation":[{"name":"13Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3089-6947","authenticated-orcid":false,"given":"Agata","family":"Pastorczak","sequence":"additional","affiliation":[{"name":"14Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutte","family":"van der Werff ten Bosch","sequence":"additional","affiliation":[{"name":"15Department of Pediatric Hematology and Oncology, University Hospital Brussels, Brussels, Belgium"},{"name":"16Department of Pediatrics, Paola Children\u2019s Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-6256","authenticated-orcid":false,"given":"Joost S. P.","family":"Vermaat","sequence":"additional","affiliation":[{"name":"3Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peet T. G. A.","family":"Nooijen","sequence":"additional","affiliation":[{"name":"17Pathology-DNA, Jeroen Bosch Hospital, \u2018s-Hertogenbosch, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-3302","authenticated-orcid":false,"given":"Konnie M.","family":"Hebeda","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[{"name":"4Institute of Pathology and Neuropathology, Comprehensive Cancer Center, University Hospital T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-1050","authenticated-orcid":false,"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[{"name":"18Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Han J. M.","family":"van Krieken","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-228X","authenticated-orcid":false,"given":"Patricia J. T. A.","family":"Groenen","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"van den Brand","sequence":"additional","affiliation":[{"name":"19Pathology-DNA, Rijnstate Hospital, Arnhem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8029-9230","authenticated-orcid":false,"given":"Blanca","family":"Scheijen","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"issue":"2","key":"2023101018404924700_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2023101018404924700_bib2","author":"Swerdlow","year":"2017"},{"issue":"16","key":"2023101018404924700_bib3","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10114","key":"2023101018404924700_bib4","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2017","journal-title":"Lancet"},{"issue":"17","key":"2023101018404924700_bib5","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2015.64.5648","article-title":"Eight cycles of ABVD versus four cycles of BEACOPPescalated plus four cycles of BEACOPPbaseline in stage III to IV, international prognostic score \u22653, high-risk Hodgkin lymphoma: first results of the phase III EORTC 20012 intergroup trial","volume":"34","author":"Carde","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"2023101018404924700_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11899-014-0220-7","article-title":"Relapsed Hodgkin lymphoma: management strategies","volume":"9","author":"Montanari","year":"2014","journal-title":"Curr hematol malig rep"},{"issue":"9","key":"2023101018404924700_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JCO.18.01652","article-title":"Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin lymphoma: a Nordic lymphoma epidemiology group study","volume":"37","author":"Biccler","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"2023101018404924700_bib8","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2015.65.4194","article-title":"Evaluation of the risk of relapse in classical Hodgkin lymphoma at event-free survival time points and survival comparison with the general population in British Columbia","volume":"34","author":"Hapgood","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"2023101018404924700_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.2016.71.3289","article-title":"Late relapse of classical hodgkin lymphoma: an analysis of the German Hodgkin study group HD7 to HD12 trials","volume":"35","author":"Br\u00f6ckelmann","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2023101018404924700_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-022-00674-w","article-title":"Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors","volume":"12","author":"Vassilakopoulos","year":"2022","journal-title":"Blood Cancer J"},{"issue":"1","key":"2023101018404924700_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjh.18180","article-title":"Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - a study from the Danish Lymphoma Registry","volume":"198","author":"Andersen","year":"2022","journal-title":"Br J Haematol"},{"issue":"4","key":"2023101018404924700_bib12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"issue":"23","key":"2023101018404924700_bib13","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","author":"Kuppers","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2023101018404924700_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/s41375-019-0508-7","article-title":"Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS","volume":"33","author":"Scheijen","year":"2019","journal-title":"Leukemia"},{"issue":"9","key":"2023101018404924700_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jmoldx.2021.06.005","article-title":"Next-generation sequencing-based clonality assessment of ig gene rearrangements: a multicenter validation study by euroclonality-NGS","volume":"23","author":"van den Brand","year":"2021","journal-title":"J\u00a0Mol Diagn"},{"issue":"6","key":"2023101018404924700_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41379-021-00983-8","article-title":"Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements","volume":"35","author":"van Bladel","year":"2022","journal-title":"Mod Pathol"},{"issue":"8","key":"2023101018404924700_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.prp.2013.05.004","article-title":"Clonality testing of malignant lymphomas with the BIOMED-2 primers in a large cohort of 1969 primary and consultant biopsies","volume":"209","author":"Hartmann","year":"2013","journal-title":"Pathol Res Pract"},{"issue":"7","key":"2023101018404924700_bib18","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3109\/10428194.2010.486094","article-title":"Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue","volume":"51","author":"Nguyen","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2023101018404924700_bib19","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.5858\/2006-130-1772-GRACGH","article-title":"Gene rearrangement and comparative genomic hybridization studies of classic Hodgkin lymphoma expressing T-cell antigens","volume":"130","author":"Aguilera","year":"2006","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"2023101018404924700_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.191.2.387","article-title":"Rare occurrence of classical Hodgkin's disease as a T cell lymphoma","volume":"191","author":"Muschen","year":"2000","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"2023101018404924700_bib21","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood.V95.10.3020","article-title":"Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease","volume":"95","author":"Seitz","year":"2000","journal-title":"Blood"},{"issue":"12","key":"2023101018404924700_bib22","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800473","article-title":"Rare expression of T-cell markers in classical Hodgkin's lymphoma","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"issue":"9","key":"2023101018404924700_bib23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/01.LAB.0000027839.98023.5A","article-title":"T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction","volume":"82","author":"Willenbrock","year":"2002","journal-title":"Lab Invest"},{"issue":"9","key":"2023101018404924700_bib24","first-page":"11372","article-title":"MUM-1 expression differentiates AITL with HRS-like cells from cHL","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"12","key":"2023101018404924700_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/diagnostics10121019","article-title":"Hodgkin Reed-Sternberg-like cells in non-Hodgkin lymphoma","volume":"10","author":"Parente","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"2023101018404924700_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","article-title":"How I diagnose angioimmunoblastic T-cell lymphoma","volume":"156","author":"Xie","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"2023101018404924700_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.5858\/arpa.2015-0197-RAI","article-title":"Reed-Sternberg-like cells in non-Hodgkin lymphomas","volume":"139","author":"Gomez-Gelvez","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2023101018404924700_bib28","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"22","key":"2023101018404924700_bib29","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.3390\/cancers13225605","article-title":"Genomic landscape of Hodgkin lymphoma","volume":"13","author":"Brune","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"13","key":"2023101018404924700_bib30","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3390\/cancers14133222","article-title":"Novel approaches in molecular characterization of classical Hodgkin lymphoma","volume":"14","author":"van Bladel","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2023101018404924700_bib31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"issue":"8","key":"2023101018404924700_bib32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod Pathol"},{"issue":"9","key":"2023101018404924700_bib33","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A\u00a0targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"issue":"14","key":"2023101018404924700_bib34","first-page":"1590","article-title":"Clonal hematopoiesis: mechanisms driving dominance of stem cell clones","volume":"136","author":"Challen","year":"2020","journal-title":"Blood"},{"key":"2023101018404924700_bib35","doi-asserted-by":"crossref","first-page":"101001","DOI":"10.1016\/j.blre.2022.101001","article-title":"CHIPing away the progression potential of CHIP: a new reality in the making","volume":"58","author":"Xie","year":"2023","journal-title":"Blood Rev"},{"issue":"3","key":"2023101018404924700_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2643-3230.BCD-20-0203","article-title":"Dissecting clonal hematopoiesis in tissues of classical Hodgkin lymphoma patients","volume":"2","author":"Venanzi","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"16","key":"2023101018404924700_bib37","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-10-1271","article-title":"Clonal relationship of classical hodgkin lymphoma and its recurrences","volume":"17","author":"Obermann","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2023101018404924700_bib38","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41375-019-0496-7","article-title":"Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study","volume":"33","author":"Bruggemann","year":"2019","journal-title":"Leukemia"},{"key":"2023101018404924700_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-0716-2115-8_2","article-title":"Next-generation sequencing-based clonality detection of immunoglobulin gene rearrangements in B-cell lymphoma","volume":"2453","author":"van Bladel","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"3","key":"2023101018404924700_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/bioinformatics\/btw634","article-title":"ARResT\/interrogate: an interactive immunoprofiler for IG\/TR NGS data","volume":"33","author":"Bystry","year":"2017","journal-title":"Bioinformatics"},{"issue":"6","key":"2023101018404924700_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jmoldx.2020.02.009","article-title":"Evaluation of a hybrid capture-based pan-cancer panel for analysis of treatment stratifying oncogenic aberrations and processes","volume":"22","author":"Kroeze","year":"2020","journal-title":"J\u00a0Mol Diagn"},{"issue":"5","key":"2023101018404924700_bib42","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1080\/10428194.2021.2015589","article-title":"Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing","volume":"63","author":"de Groot","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"10310","key":"2023101018404924700_bib43","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"2023101018404924700_bib44","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/cncr.20189","article-title":"Familial aggregation of Hodgkin lymphoma and related tumors","volume":"100","author":"Goldin","year":"2004","journal-title":"Cancer"},{"issue":"7","key":"2023101018404924700_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM199502163320701","article-title":"Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease","volume":"332","author":"Mack","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2023101018404924700_bib46","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/1055-9965.EPI-14-0683","article-title":"Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms","volume":"23","author":"Kushekhar","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"14","key":"2023101018404924700_bib47","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.0915054107","article-title":"HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma","volume":"107","author":"Hjalgrim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2023101018404924700_bib48","doi-asserted-by":"crossref","first-page":"e39986-39994","DOI":"10.1371\/journal.pone.0039986","article-title":"HLA associations in classical Hodgkin lymphoma: EBV status matters","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"2023101018404924700_bib49","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood-2007-05-086934","article-title":"HLA-A\u221702 is associated with a reduced risk and HLA-A\u221701 with an increased risk of developing EBV+ Hodgkin lymphoma","volume":"110","author":"Niens","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2023101018404924700_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2009.07946.x","article-title":"IRF4 polymorphism rs872071 and risk of Hodgkin lymphoma","volume":"148","author":"Broderick","year":"2010","journal-title":"Br J Haematol"},{"issue":"3","key":"2023101018404924700_bib51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08632.x","article-title":"Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph)","volume":"153","author":"Butterbach","year":"2011","journal-title":"Br J Haematol"},{"issue":"1","key":"2023101018404924700_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mc.20688","article-title":"Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes","volume":"50","author":"Monroy","year":"2011","journal-title":"Mol Carcinog"},{"issue":"8","key":"2023101018404924700_bib53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.gene.6364337","article-title":"Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk","volume":"7","author":"Nieters","year":"2006","journal-title":"Genes Immun"},{"issue":"11","key":"2023101018404924700_bib54","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood.2022016056","article-title":"Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma","volume":"141","author":"Flerlage","year":"2023","journal-title":"Blood"},{"key":"2023101018404924700_bib55","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1038\/ncomms4856","article-title":"A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus","volume":"5","author":"Cozen","year":"2014","journal-title":"Nat Commun"},{"issue":"2","key":"2023101018404924700_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/08880018.2019.1710310","article-title":"CTLA4 haploinsufficiency as a predisposition to classical Hodgkin lymphoma","volume":"37","author":"Mahat","year":"2020","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"2023101018404924700_bib57","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3324\/haematol.2019.216317","article-title":"An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma","volume":"105","author":"Record","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"2023101018404924700_bib58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.13295","article-title":"Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing","volume":"170","author":"Ristolainen","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"2023101018404924700_bib59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3324\/haematol.2015.135475","article-title":"Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene","volume":"101","author":"Rotunno","year":"2016","journal-title":"Haematologica"},{"key":"2023101018404924700_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fbioe.2020.00179","article-title":"Identification of familial Hodgkin lymphoma predisposing genes using whole genome sequencing","volume":"8","author":"Srivastava","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"2023101018404924700_bib61","doi-asserted-by":"crossref","first-page":"e1295202-1295209","DOI":"10.1080\/2162402X.2017.1295202","article-title":"HLA dependent immune escape mechanisms in B-cell lymphomas: implications for immune checkpoint inhibitor therapy?","volume":"6","author":"Nijland","year":"2017","journal-title":"Oncoimmunology"},{"issue":"5","key":"2023101018404924700_bib62","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3324\/haematol.2022.280840","article-title":"Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nation-wide cohort: implications for clinical and epidemiological studies authors","volume":"108","author":"Boot","year":"2023","journal-title":"Haematologica"},{"key":"2023101018404924700_bib63","doi-asserted-by":"crossref","first-page":"100986","DOI":"10.1016\/j.blre.2022.100986","article-title":"Game of clones: diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma","volume":"56","author":"Meier","year":"2022","journal-title":"Blood Rev"},{"issue":"10","key":"2023101018404924700_bib64","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMc1806413","article-title":"High-risk clonal hematopoiesis as the origin of AITL and NPM1-mutated AML","volume":"379","author":"Tiacci","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"2023101018404924700_bib65","first-page":"1599","article-title":"Clonal hematopoiesis and risk for hematologic malignancy","volume":"136","author":"Warren","year":"2020","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5911\/2083671\/blooda_adv-2023-010412-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/19\/5911\/2083671\/blooda_adv-2023-010412-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T18:47:46Z","timestamp":1696963666000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/19\/5911\/497354\/A-significant-proportion-of-classic-Hodgkin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":65,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010412","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}